Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a daily Under-the-Tongue spray cut COPD attacks?

NCT ID NCT01842360

Completed Disease control Sponsor: Inmunotek S.L. Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 28 times

Summary

This study tested whether a bacterial vaccine called MV130, taken daily under the tongue for 12 months, could reduce the number and severity of flare-ups in adults with moderate to severe COPD. Researchers compared it to a placebo in 198 participants and followed them for 18 months. The goal was to see if the vaccine could help manage the disease and improve quality of life, though it is not a cure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Hospital Clínico San Carlos

    Madrid, 28040, Spain

  • Hospital General Universitario Gregorio Marañón

    Madrid, 28007, Spain

  • Hospital Universitario 12 de Octubre

    Madrid, 28041, Spain

  • Hospital Universitario Infanta Leonor

    Madrid, 28031, Spain

  • Hospital Universitario La Paz

    Madrid, 28046, Spain

  • Hospital Universitario de Torrejón

    Torrejón de Ardoz, Madrid, 28850, Spain

  • Hospital Universitario de Vic

    Vic, Barcelona, 08500, Spain

Conditions

Explore the condition pages connected to this study.

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)